GENcast: 3D Cell Models Push Drug Discovery Screening into High Gear
In this GENcast, our guest will tell us more about HTS using 3D cell models and why they are so crucial for current drug discovery projects. Moreover, he will provide scientific insight into the 3D cell panel screening service—called OncoSignature™—which uses a library of 200 cell lines grown in 3D spheroids to provide a better understanding of candidate cancer therapeutics.
GENcast: Reducing Drug Discovery and Development Risk with Mechanistic Modeling
In this GENcast, sponsored by Applied BioMath, we sat down with an expert in mechanistic modeling to discuss the specific of this approach and how companies are employing the technology successfully
Impact of COVID-19 on the Life Science Industry
In this sponsored GENcast listen to a conversation with Dr. Klaus Lun, Executive Vice President of Life Science Business for Tecan, provide his perspective on global developments pertaining to COVID-19 and other timely topics.
Moving the Drug Pipeline Forward with Mechanistic Modeling
In this GENcast, sponsored by Applied BioMath, we sat down with an expert in mechanistic modeling to discuss the specific of this approach and how companies are employing the technology successfully.
Reliable Single Cell Outgrowth: Dark Art or Science?
In this GEN webinar, we will discuss how the VIPS™ (Verified in-situ Plate Seeding) system, in combination with the SAL Scientific single-cell cloning supplements, offer customers a high-efficiency solution which ensures plates are populated with high numbers of healthy single cells that grow into resultant colonies for screening, expansion and further selection to master cell banks.
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
REGISTER NOW
Broadcast Date: February 5, 2019Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Antibody-drug conjugates select ADCs) were initially developed to provide a selective targeting mechanism...
Next-Gen IR Spectroscopy of Protein Structure Perturbed by Pressure
In this GEN webinar, we will review pressure-assisted protein refolding and pressure perturbation coupled with MMS to study protein stability in biopharmaceutical formulations.
Self-Amplifying mRNA Vaccines for Pandemic Rapid Response
In this GEN webinar, sponsored by TriLink Biotechnologies, we will hear about data innovations from seven years of research at Novartis Vaccines on self-amplifying mRNA technology and how this approach could enable the concept of vaccines on demand as a rapid response to a real threat rather that the deployment of strategic stockpiles based on epidemiological predictions of a possible threat.
Exploring Novel Vaccine Characterization Methodologies
In this GEN webinar, we will discuss some typical workflows used to characterize the properties of vaccines, looking at properties such as particle size, surface charge, aggregation, and protein secondary structure.
